MS Medications: Injections, Infusions, and Oral Drugs

Multiple sclerosis (MS) drugs can modify disease progression, treat relapses, and more. Learn about over 50 MS drugs, like Tecfidera and Ocrevus.

Multiple Sclerosis and Medicare Coverage | GoHealth

Learn about multiple sclerosis and Medicare, including coverage for MS drugs and disease-modifying therapy.

MS drug almost halves hospitalised patients' risk of severe Covid symptoms

A drug used for multiple sclerosis nearly halves the chance of developing severe coronavirus symptoms in hospitalised patients and may prevent deaths, a new trial has shown...

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic - NPR

January 20, 2020 · 9:00 AM ET · By Sydney Lupkin ; "They are extremely expensive," says Ewing-Wilson. On average, the medicines cost $70,000 per year, according to a 2017 study. Some prices have increased fivefold from when the drugs were first approved by the Food and Drug Administration. Even with insurance, says Ewing-Wilson, patients can be left on the hook for anywhere from $3,000 to more than $50,000 a year. Some patients tell her they need to skip their medications altogether because they're unaffordable. ...

MS drug development poses a big challenge for pharma

[Reporter's View] ‘Tyranny of Drug Committees persist' ; [Reporter’s View] Vaccine sovereignty only during epidemics ; [Reporter's View] pros and cons of concurrent reimb listing

Serono Purchases Rights To Experimental MS Drug

What to Read Next ; First Novel Schizophrenia Treatment in Decades Gains FDA Approval ; Sanofi Earnings Get Boost From Early Vaccine Sales ; Sanofi Enters Exclusive Talks With CD&R Over Consumer Business Stake Sale ; How Israel Pulled Off Its Largest-Ever Strike on Iran

Researchers see success in trial for first generic MS drug, paving way for more

“Unlike what are so-called ‘small’ molecule [drugs]— aspirin, acetaminophen—for large, very-complicated molecules [in MS drugs], relatively small changes in how they’re...

Sanofi's mixed fortunes in MS drug trials has market focus on win

They are designed to selectively block the harmful autoimmune reaction behind MS for a more targeted approach than standard immunosuppressant drugs. Investors however have been kept on edge...

Medications for Multiple Sclerosis

Many medications can slow down MS in some people. Doctors call them disease-modifying drugs. They include: Alemtuzumab (Lemtrada) Cladribine (Mavenclad) Dimethyl fumarate (Tecfidera)...

Merck KGaA suffers major blow as MS drug fails in late-stage trials

Advertisement · Scroll to continue Merck was seen as ahead of Sanofi (SASY.PA) , Novartis (NOVN.S) and Roche (ROG.S) in a four-way race to develop more targeted MS drugs in a class known...